SEC Form D private-offering filing

FibroBiologics, Inc.

A new SEC Form D private-offering notice from Houston, TX, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.

FibroBiologics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing fibroblast cell-based therapies for chronic diseases, including multiple sclerosis, degenerative disc disease and wound healing.

Filed 2026-06-29Filed to raise $3,000,000First money in 2026-06-25Raised so far $3,000,000HQ (as filed) Houston, TXSector Biotech ✓Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified fibrobiologics.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.